Tag Archives: Top pharma eyes approval of COVID-19 vaccine by first half of 2021

PARIS: French drugmaker Sanofi said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain’s GlaxoSmithKline by the first half of next year, faster than previously anticipated. Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be available in the second …

Read More »